---
figid: PMC7778590__thnov11p1753g005
figlink: pmc/articles/PMC7778590/figure/F5/
number: F5
caption: Targeting YAP for PDAC therapy. There are several strategies for targeting
  YAP in PDAC. Statin-mediated inhibition of HMG-CoA reductase in the mevalonate pathway
  reduces the geranylgeranylation and membrane localization of Rho GTPases, restricting
  YAP nuclear accumulation and thus its activity. Verteporfin and VGLL4-mimicking
  peptides disrupt the interaction between YAP and TEAD, inhibiting YAP-induced transcription.
  Metformin activates AMPK, which inhibits YAP both directly and by activating LATS
  kinases. BET inhibitors oppose the transcription of YAP-regulated genes. Neratinib
  increases the phosphorylation of LATS1 and YAP, causing YAP cytosolic accumulation
  and degradation.
pmcid: PMC7778590
papertitle: 'YAP in pancreatic cancer: oncogenic role and therapeutic strategy.'
reftext: Wenhao Mao, et al. Theranostics. 2021;11(4):1753-1762.
pmc_ranked_result_index: '73546'
pathway_score: 0.9252146
filename: thnov11p1753g005.jpg
figtitle: Targeting YAP for PDAC therapy
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7778590__thnov11p1753g005.html
  '@type': Dataset
  description: Targeting YAP for PDAC therapy. There are several strategies for targeting
    YAP in PDAC. Statin-mediated inhibition of HMG-CoA reductase in the mevalonate
    pathway reduces the geranylgeranylation and membrane localization of Rho GTPases,
    restricting YAP nuclear accumulation and thus its activity. Verteporfin and VGLL4-mimicking
    peptides disrupt the interaction between YAP and TEAD, inhibiting YAP-induced
    transcription. Metformin activates AMPK, which inhibits YAP both directly and
    by activating LATS kinases. BET inhibitors oppose the transcription of YAP-regulated
    genes. Neratinib increases the phosphorylation of LATS1 and YAP, causing YAP cytosolic
    accumulation and degradation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SAV1
  - MST1
  - STK3
  - LATS1
  - LATS2
  - MOB1A
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - YY1AP1
  - RHOD
  - CTGF
  - CYR61
  - Mevalonate
  - Statins
  - Metformin
  - Mevalonic acid
  - Neratinib
  - Verteporfin
genes:
- word: SAV1
  symbol: SAV1
  source: hgnc_symbol
  hgnc_symbol: SAV1
  entrez: '60485'
- word: MST1/2
  symbol: MST1
  source: hgnc_symbol
  hgnc_symbol: MST1
  entrez: '4485'
- word: MST1/2
  symbol: MST2
  source: hgnc_alias_symbol
  hgnc_symbol: STK3
  entrez: '6788'
- word: LATS1/2
  symbol: LATS1
  source: hgnc_symbol
  hgnc_symbol: LATS1
  entrez: '9113'
- word: LATS1/2
  symbol: LATS2
  source: hgnc_symbol
  hgnc_symbol: LATS2
  entrez: '26524'
- word: МОВ1
  symbol: MOB1
  source: hgnc_alias_symbol
  hgnc_symbol: MOB1A
  entrez: '55233'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: YAP
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: Rho
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
- word: CTGF
  symbol: CTGF
  source: hgnc_symbol
  hgnc_symbol: CTGF
  entrez: '1490'
- word: YAP
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: CYR61
  symbol: CYR61
  source: hgnc_symbol
  hgnc_symbol: CYR61
  entrez: '3491'
chemicals:
- word: Mevalonate
  source: MESH
  identifier: D008798
- word: Statins
  source: MESH
  identifier: D019821
- word: Metformin
  source: MESH
  identifier: D008687
- word: Mevalonic acid
  source: MESH
  identifier: D008798
- word: Neratinib
  source: MESH
  identifier: C487932
- word: Verteporfin
  source: MESH
  identifier: C098350
diseases: []
figid_alias: PMC7778590__F5
redirect_from: /figures/PMC7778590__F5
figtype: Figure
---
